Inspiring better decisions through economics and finance
1,400 investors forced to wait a decade for compensation after collapse of Custom House CapitalOxera submits Expert Report on behalf of investors A new landmark ruling by the Irish High Court has determined that almost 1,400 investors who had been left out of pocket by Custom House Capital must be… Read More
The latest empirical evidence from Oxera shows that ex ante regulation could reduce expenditure in innovation by up to €3.4bn per year and stifle new services for consumers In December 2020, the European Commission proposed new regulation known as the Digital Markets Act (DMA) in which it stated that… Read More
Oxera’s latest report explains how the Digital Markets Act (DMA) could prohibit several common business practices, found offline as well as online, that generate value for consumers and have positive effects on society. In December 2020, the European Commission tabled proposals for the DMA, which will… Read More
We are delighted to be growing our senior team internationally with the promotion of five Senior Consultants to Principal grade. In recognition of their considerable success, Oxera has promoted five Senior Consultants to the Principal grade: Christopher Davis, Mohammed Khalil, Dr Nicole Rosenboom, Kimela Shah and Gareth Shier. Chris… Read More
Oxera today announces the appointment of two Chief Operating Officers, Deborah Stump and Andrew Judt. Andrew Judt and Deborah Stump’s new roles and partnership are set to enable significant growth for the economics consultancy. They will be working together as a COO team, bringing their complementary skills and… Read More
The study is the first independent analysis of real-world UK airport data collected from 71,000 tests using data from airline trials and testing at Heathrow over the last six monthsThe real-world findings from the airline trials involving American Airlines, British Airways, United Airlines and Virgin Atlantic indicate that 74% of… Read More
Rising immunity in the UK means that more than 100 countries could open up to UK visitors without an increase in risk, if case rates are similar to last summerWith high-performing antigen tests administered pre-departure, the list could increase to more than 130 with the same level of accepted riskUK’s… Read More
International travel could safely reopen through the widespread adoption of high-quality rapid antigen testing shows new research. The study carried out by Oxera and Edge Health shows that antigen testing can be highly effective in detecting COVID-19 infections. The new modelling also shows that the current ten-day quarantine period required… Read More
A single on-arrival antigen test is as effective as a ten-day self-isolation period in reducing imported cases of COVID-19, new modelling has revealed. Based on prevalence rates at home and abroad and accounting for quarantine compliance, Oxera and Edge Health find that a single rapid antigen test would be appropriate… Read More
On 4 February 2021, economics and finance consultancy Oxera hosted a virtual roundtable discussion between regulators, platforms, advisers and academics on the future of digital. The discussion centred on how to ensure that consumers and businesses continue to enjoy the varied benefits that digital services unlock. The summary provides… Read More
We are pleased to announce that Oxera has received several nominations in the 2021 Global Competition Review awards. A number of cases that our experts worked on in 2020 have been shortlisted: Intesa Sanpaolo/UBI Banca (Merger control matter of the year – Europe) Daimler roll-on roll-off damages claims (Litigation of… Read More
Oxera is acting as economic expert for Which?, the UK’s independent consumer representative, in a landmark UK collective action against US-based wireless technology firm Qualcomm. Qualcomm develops wireless technology and holds standard-essential patents (SEPs) that are necessary inputs for handset manufacturers wishing to implement cellular standards… Read More
Oxera Partner Pascale Déchamps takes on a new role at the French Competition Authority. Pascale joined Oxera in 2013 and has made a remarkable contribution to the firm’s growth. Her expertise, experience and passion for economics have been recognised on numerous occasions by clients, regulators and judges, and formally by… Read More
Oxera’s latest report shows that including AV within the scope of the EU’s 2018 Geoblocking Regulation—even with a requisite rights limitation—would erode the contractual freedoms that traders (including producers, distributors, cinemas and broadcasters) rely on to fund new content production and distribution. In 2016, Oxera published a report jointly… Read More
Peter-Carlo Lehrell joins Oxera as Senior Adviser and Director Oxera is pleased to announce that Peter-Carlo has joined Oxera’s leadership team as a Senior Adviser and Director, assisting the firm with international business development and strategy. Commenting on the appointment, Oxera Partner Sir Philip Lowe said: ‘We are very… Read More
Oxera’s latest report shows that regulation of digital markets risks disadvantaging European consumers and businesses. In June 2020, the European Commission made a series of proposals affecting digital markets. These proposals include a form of ex ante regulation, which has become known as the Digital Markets Act and is… Read More